Resources
Big Molecule Watch
- Court Cancels Injunction Hearings In Aflibercept BPCIA Litigation; Regeneron May Seek Temporary Restraining Orders May 10, 2024 Joshua Weinger
- IRA Litigation Updates: D.N.J. Rejects Challenges from BMS and Janssen; Four Cases Now on Appeal May 9, 2024 Alexandra Lu
- FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and Biosimilars May 3, 2024 Julie Tibbets|Daniel Farraye
- Accord BioPharma, Inc. Announces FDA Approval of HERCESSI (trastuzumab-strf) May 2, 2024 Gabriella Montes
- PTAB Issues Final Written Decisions Finding Claims of Recombinant Lentiviral Vector Patents Valid May 1, 2024 Lihui Bai
- Biosimilar Approval Updates in Europe and China April 30, 2024 Kristin Beale
- GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech for Infringing mRNA Vaccine Patents April 29, 2024 Elaine Blais
- Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR April 29, 2024 Timothy Beavers|Natasha Daughtrey
- Alvotech Announces Positive Topline Results From Confirmatory Clinical Study for its Proposed Golimumab Biosimilar April 26, 2024 Timothy Beavers
- FDA Approval of Alvotech/Teva Ustekinumab Biosimilar April 23, 2024 Seth Manilove
BioPharma Reporter
- Regeneron gene therapy restores hearing in profoundly deaf child May 13, 2024
- Anticipation mounts as Insmed's bronchiectasis therapy nears phase 3 completion May 13, 2024
- Circio debuts proof-of-concept for circVec gene therapy at ASGCT 2024 May 13, 2024
- Asia Pacific region leads in asthma clinical trials between 2019-2023 May 9, 2024
- Calliditas announces positive topline results of phase 2 head and neck cancer trial May 9, 2024
- Commit Biologics advances complement platform with €16m seed financing May 9, 2024
- Courtney Noah on how it's time the STEM industry provides more opportunities for women May 8, 2024
- Samsung Biologics poised for growth pending BIOSECURE bill approval in US May 7, 2024
- What innovations are reshaping the pharma services sector? May 7, 2024
- Broken String Biosciences to advance ALS research with Francis Crick Institute May 7, 2024